U.S., March 28 -- ClinicalTrials.gov registry received information related to the study (NCT07497074) titled 'JSKN033 Combination Therapy in Subjects With Advanced Cervical Cancer' on March 10.
Brief Summary: The goal of this clinical trial is to learn if the therapy of JSKN033 plus chemotherapy with or with bevacizumab is safe to treat patients with advanced cervical cancer. It will also learn about the antitumor activity and pharmacokinetic/ pharmacodynamic profiles of this therapy.
Study Start Date: April, 2026
Study Type: INTERVENTIONAL
Condition:
Cervical Cancer
Intervention:
DRUG: JSKN033
JSKN033 in combination with platinum-based chemotherapy with or without bevacizumab at selected dose levels according to protocol
DRUG: Pla...